LATEST
Janel agreed to acquire EnCor BiotechnologynewNightfood Holdings acquired Jun Long Machine IndustrialnewClimb Global Solutions acquired NeoVADnewValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range IntermediateBose acquired Skullcandy
Open App
Agreement signedPublished 31 May 2022

Regeneron Pharmaceuticals, Inc. /
Checkmate Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. agrees to buy Checkmate Pharmaceuticals, Inc.

Price per share
$10.50/share
Stage
Agreement signed
Source · 31 May 2022
See the source
01 / BuyerRegeneron Pharmaceuticals, Inc.
02 / TargetCheckmate Pharmaceuticals, Inc.
01

What happened

Regeneron Pharmaceuticals, Inc. agreed to acquire Checkmate Pharmaceuticals, Inc. for $10.50 per share, according to a filing dated May 31, 2022.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Regeneron Pharmaceuticals, Inc. agrees to buy Checkmate Pharmaceuticals, Inc.

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.